IceCure Medical Marks Milestone in Kidney Cancer Cryoablation Study with 5-Year Follow-Up Outcomes IceCure Medical has completed a significant 5-year follow-up in its ICESECRET kidney cancer cryoablation study. Final analysis is anticipated by Q2 2026.

IceCure Medical Marks Milestone in Kidney Cancer Cryoablation Study with 5-Year Follow-Up Outcomes #Israel #Caesarea #IceCure_Medical #ProSense #Kidney_Cancer

Editorial comments © 2021 by Neil E Clement depicting a photo of a bearded bald white man wearing an off-white golf shirt covered with tiny multi-colored golf flags standing on the back of a ferry boat looking at the viewer with the white jet-spray flying away behind him and the blue sky rising above the dark landline in the distance and saying this: FOREVER CHEMICALS (underlined & centered in dark blue letters) black letters: OK, well, humanity has managed to seriously poison its own global environment with microplastics, pesticides and something called PFAs, all of which are terribly, terribly poisonous, all of which are in our bodies right now thanks to industry producing and discarding them into the natural environment since the early 20th century, and, as a special bonus, they last forever. This all adds to our other prodigious garbage output. red letters and centered: NOW WE FIND OUT THERE ARE ACTUALLY FOUR TIMES AS MANY PFAs THAN PREVIOUSLY KNOWN TAPS is playing out all over America and the world every second of every day. (TAPS - The Absolute Power Syndrome) more info: #PFAs #PFAS #MICROPLASTICS #PESTICIDES AUG 2025: #Perfluoroalkoxy_alkane / #Polyfluoroalkoxy_alkane These #FOREVER_CHEMICALS saturate our entire #ecosystem. Known to cause #kidney_cancer... and other #cancers as well. Photo & Contents © 2021 Neil E Clement, All Rights Reserved

#PFAs #PFAS #MICROPLASTICS #PESTICIDES #CHMICALS
AUG 2025: #Perfluoroalkoxy_alkane / #Polyfluoroalkoxy_alkane
These #FOREVER_CHEMICALS saturate our entire #ecosystem.
Known to cause #kidney_cancer... and other #cancers as well.

Oncorena Raises 133 Million SEK to Advance Metastatic Kidney Cancer Study Oncorena's latest share issue raised 133 million SEK to support its clinical study ONC175, a promising treatment for metastatic renal cell carcinoma.

Oncorena Raises 133 Million SEK to Advance Metastatic Kidney Cancer Study #Sweden #Lund #Kidney_Cancer #Oncorena #ONC175

Oncorena Achieves Full Subscription of New Share Issuance, Raises 133 Million SEK Oncorena's latest share issuance attracted full subscriptions totaling 133 million SEK, funding crucial cancer drug studies. The future looks promising as investor confidence grows.

Oncorena Achieves Full Subscription of New Share Issuance, Raises 133 Million SEK #Sweden #Lund #Kidney_Cancer #Oncorena #ONC175

Okayama University Pioneers Laser Treatment to Avoid Dialysis for Kidney Cancer Okayama University is at the forefront of using laser technology for minimally invasive kidney cancer treatments, aiming to preserve kidney function and avoid dialysis.

Okayama University Pioneers Laser Treatment to Avoid Dialysis for Kidney Cancer #Japan #Kidney_Cancer #Okayama #Okayama_University #Laser_Treatment

Medical*Online Video Launches New Kidney Cancer Guidelines and 3D Imaging Videos Medical*Online Video is introducing new educational videos on kidney cancer guidelines and 3D imaging for healthcare professionals and students.

Medical*Online Video Launches New Kidney Cancer Guidelines and 3D Imaging Videos #Japan #Tokyo #Kidney_Cancer #3D_imaging #Medical*Online_Video

IceCure Medical Presents Promising Results for Kidney Cancer Cryoablation Therapy at European Conference IceCure Medical shared promising interim results of its cryoablation therapy for kidney tumors at a major urology conference in Spain, showing an 88.7% recurrence-free rate.

IceCure Medical Presents Promising Results for Kidney Cancer Cryoablation Therapy at European Conference #Spain #Madrid #IceCure_Medical #Kidney_Cancer #ProSense_Cryoablation

Oncorena Gains FDA Approval for Groundbreaking Kidney Cancer Study in the US Oncorena's FDA approval paves the way for its Phase I/II clinical study, offering hope for renal cancer patients in urgent need of new treatments.

Oncorena Gains FDA Approval for Groundbreaking Kidney Cancer Study in the US #USA #Houston #Kidney_Cancer #Oncorena #ONC175

IceCure's ProSense® Cryoablation Shows Promising Results in Treating Kidney Tumors IceCure Medical announces encouraging interim results from their ICESECRET study, showing an 88.7% recurrence-free rate for kidney tumors treated with ProSense® cryoablation.

IceCure's ProSense® Cryoablation Shows Promising Results in Treating Kidney Tumors #Israel #IceCure_Medical #ProSense® #Kidney_Cancer #Eilat